Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Fibrinogen concentrate for bleeding - a systematic review

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Continuous vital sign monitoring after major abdominal surgery-Quantification of micro events

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Corticosteroids and risk of gastrointestinal bleeding in critically ill adults: Protocol for a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  4. Pre-operative haemodynamic monitoring and resuscitation in hip fracture patients: Protocol for a prospective observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The association between pre-operative sepsis and 30-day mortality in hip fracture patients-A cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. European Guidelines on perioperative venous thromboembolism prophylaxis: Executive summary

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Early Identification of the Patient with Endotheliopathy of Trauma by Arrival Serum Albumin

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Thrombelastography Early Amplitudes in bleeding and coagulopathic trauma patients: Results from a multicenter study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Fibrinogen concentrate as part of treatment protocols increasingly draws attention. Fibrinogen substitution in cases of hypofibrinogenaemia has the potential to reduce bleeding, transfusion requirement and subsequently reduce morbidity and mortality. A systematic search for randomised controlled trials (RCTs) and non-randomised studies investigating fibrinogen concentrate in bleeding patients was conducted up to November 2013. We included 30 studies of 3480 identified (7 RCTs and 23 non-randomised). Seven RCTs included a total of 268 patients (165 adults and 103 paediatric), and all were determined to be of high risk of bias and none reported a significant effect on mortality. Two RCTs found a significant reduction in bleeding and five RCTs found a significant reduction in transfusion requirements. The 23 non-randomised studies included a total of 2825 patients, but only 11 of 23 studies included a control group. Three out of 11 found a reduction in transfusion requirements while mortality was reduced in two and bleeding in one. In the available RCTs, which all have substantial shortcomings, we found a significant reduction in bleeding and transfusions requirements. However, data on mortality were lacking. Weak evidence from RCTs supports the use of fibrinogen concentrate in bleeding patients, primarily in elective cardiac surgery, but a general use of fibrinogen across all settings is only supported by non-randomised studies with serious methodological shortcomings. It seems pre-mature to conclude whether fibrinogen concentrate has a routine role in the management of bleeding and coagulopathic patients. More RCTs are urgently warranted.

Original languageEnglish
JournalActa anaesthesiologica Scandinavica
Volume58
Issue number9
Pages (from-to)1061-74
ISSN0001-5172
DOIs
StatePublished - 24 Jul 2014

ID: 44470818